Skip to contentSkip to Braille Studio

Library / Laws / 118th Congress / Senate Bills / S. 4426

S. 4426

To amend the Federal Food, Drug, and Cosmetic Act to establish a time-limited conditional approval pathway, subject to specific obligations, for certain drugs and biological products, and for other purposes.

Print stageDateSize⠃
Introduced in Senate2024-05-2325.9K⠃⠗⠋